These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 739656)

  • 21. [The lymphocytes of the patients with hypoplastic anemia (author's transl)].
    Arimori S; Kobashi H; Tada S; Ichikawa Y; Koriyama K
    Rinsho Ketsueki; 1975 Aug; 16(8):763-7. PubMed ID: 1237637
    [No Abstract]   [Full Text] [Related]  

  • 22. Skin test sensitivity and antigen-induced lymphocyte transformation in uraemia.
    Selroos O; Pasternack A; Virolainen M
    Clin Exp Immunol; 1973 Jul; 14(3):365-70. PubMed ID: 4725396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The trehalose tolerance test in the investigation of intestinal absorption in uraemic patients on intermittent haemodialysis (author's transl)].
    Pointner H; Flegel U; Bayer PM; Schmidt P
    Wien Klin Wochenschr; 1974 Nov; 86(22):691-3. PubMed ID: 4460392
    [No Abstract]   [Full Text] [Related]  

  • 24. [Acute pericarditis treatment during maintenance hemodialysis (author's transl)].
    Di Marco V; Ginardi V; Mazzone O; Trovato GM
    G Ital Cardiol; 1980; 10(1):79-83. PubMed ID: 7461311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [PHA induced cytotoxicity. 1. Its concept and clinical significance (author's transl)].
    Hata M; Aoki S; Jitsukawa S; Yoshida T; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1977 Mar; 68(3):225-30. PubMed ID: 558447
    [No Abstract]   [Full Text] [Related]  

  • 26. [A gas chromatographic-mass spectrometric analysis of organic acids in uremic ultrafiltrate (author's transl)].
    Maeda K; Niwa T; Kobayashi K
    Nihon Jinzo Gakkai Shi; 1981 Jan; 23(1):75-88. PubMed ID: 7289205
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunological aspects of psoriasis (author's transl)].
    Vosmík F; Hausner P; Votava L; Fucíková T; Pekárek J
    Cesk Dermatol; 1979 Jun; 54(3):123-31. PubMed ID: 316365
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lymphocyte transformation test in fixed drug eruption--changes at various stages including clinical exacerbation and remission after the challenge (author's transl)].
    Asai Y; Suzuki S; Hosoi Y; Hamada T
    Nihon Hifuka Gakkai Zasshi; 1980; 90(3):249-53. PubMed ID: 6445016
    [No Abstract]   [Full Text] [Related]  

  • 29. [Possibilities for the use of adsorbers for bloodcleaning in case of uremia (author's transl)].
    Pasternack A
    Biomed Tech (Berl); 1975 Dec; 20(6):229-37. PubMed ID: 1243102
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of varying dialysis regimens on lymphocyte stimulation.
    Hurst KS; Saldanha LF; Steinberg SM; Galen MA; Lowrie EG; Gagneux SA; Lazarus JM; Strom TB; Carpenter CB; Merrill JP
    Trans Am Soc Artif Intern Organs; 1975; 21():329-34. PubMed ID: 1146004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Medium molecules in uremia. Isolation techniques, chemical determination, biological tests, and the effects of dialysis].
    Buzio C; Manari A; Montagna G; Arisi L; Calderini C; Savazzi G; Migone L
    Minerva Nefrol; 1980; 27(3):483-94. PubMed ID: 7231798
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on the factors contributing to uremic dyslipoproteinemia].
    Handa Y; Arita T; Hesaka K; Ishine K; Ohta N
    Nihon Jinzo Gakkai Shi; 1984 Jan; 26(1):51-61. PubMed ID: 6737784
    [No Abstract]   [Full Text] [Related]  

  • 33. Fibrinolytic activity and recalcified plasma clotting time in uremia.
    Bector NP; Gupta RK; Pahuja JK
    J Assoc Physicians India; 1971 Sep; 19(9):615-8. PubMed ID: 5162126
    [No Abstract]   [Full Text] [Related]  

  • 34. [Gastrointestinal endoscopic abnormalities in uremic patients (author's transl)].
    Abraham J; García López L; Alvizouri M
    Rev Invest Clin; 1980; 32(4):409-14. PubMed ID: 7221231
    [No Abstract]   [Full Text] [Related]  

  • 35. Determination of middle molecules in uremic patients.
    Wu ZG; Cai ZH; Lu ZN; Liao LT; Zhu SQ
    Chin Med J (Engl); 1985 Feb; 98(2):115-20. PubMed ID: 3922688
    [No Abstract]   [Full Text] [Related]  

  • 36. [Inhibition of red blood cell glucose utilization in uremia].
    Gajdos M; Dzúrik R
    Vnitr Lek; 1974 Oct; 20(10):974-82. PubMed ID: 4420983
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum protein alterations in uremia.
    Morgan JM; Morgan RE; Thomas GE
    Ala J Med Sci; 1967 Jan; 4(1):68-73. PubMed ID: 6036768
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in lipid metabolism in uremia].
    Ianhez LE; Cruz O; Sabbaga E
    Rev Hosp Clin Fac Med Sao Paulo; 1976 Oct; 31(5):386-91. PubMed ID: 981882
    [No Abstract]   [Full Text] [Related]  

  • 39. [Point of micropreparative high pressure liquid chromatography and thin-layer chromatography for the identification of indole compounds in human plasma (author's transl)].
    Trefz FK; Byrd DJ; Kochen W
    J Clin Chem Clin Biochem; 1976 Feb; 14(2):65-72. PubMed ID: 1249527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A fourth possibility treating chronical uremic patients: the satellite dialysis station (author's transl)].
    Frotscher U; Hartwig H
    Med Klin; 1976 Jan; 71(3):120-3. PubMed ID: 1250191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.